Clinical Trial Vendor Oversight and Governance - WHITEPAPER
Download the exclusive whitepaper
Outsourcing of clinical trials is undertaken by pharmaceutical companies for a number of reasons including reduction of costs of conducting clinical trials, reducing wastage by engaging a vendor with manpower and expertise in the area of interest for the sponsor, and achieving reduced cycle times of introducing a new product in the market. While these reasons form the basis of outsourcing, the sponsor treads a thin line distinguishing between micromanaging each and every step and effective oversight in the implementation of the clinical trial.
This whitepaper explores:
- Vector selection: procurement strategies and contract design
- Regulatory requirements with ICH GCP guidelines
- Vendor responsibilities for data sharing with the sponsors
- Quality agreements and monitoring
- Risk minimization
- Overseeing technology vendors
To download the exclusive whitepaper simply log in or register for a KNect365 account, which will give you access to all our exclusive premium content.
ABOUT THE AUTHOR: Poonam Balani has a PhD in biomedical sciences from the University of Muenster, Germany. She has 14 years of experience in medical and academic writing and has worked as a researcher at the University of Tennessee Health Science Center, USA and the Institute for Bioengineering and Nanotechnology, Singapore.
Have any questions about the report or interested in sponsoring a future whitepaper? Email firstname.lastname@example.org.